Lunit Seoul, South Korea-based, a leading medical artificial intelligence (AI) firm that specializes in precision diagnostics and therapies, said today that it has raised $26 million in a Series C round of funding from Guardant Health.
This round was backed by Asian investors, led by Korea’s Shinhan Investment, with InterVest, IMM Investment, Kakao Ventures, and China’s Legend Capital of Lenovo Group.
Company: Lunit Inc.
Round: Series C
Funding Month: July 2021
Lead Investors: Guardant Health and Shinhan Investment
Additional Investors: InterVest, IMM Investment, Kakao Ventures, and China’s Legend Capital of Lenovo Group
Company Website: https://www.lunit.io/
Software Category: AI-powered radiology and pathology solutions
About the Company: Lunit, abbreviated from “learning unit,” is an AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.